Circulating Neoplastic Cells Summary

Networked: 1072 relevant articles (30 outcomes, 121 trials/studies) for this Disease

Key Drugs and Agents for Circulating Neoplastic Cells

1. Biological Markers (Surrogate Marker) : 5 outcomes 13 studies in 143 results : IBA
   
2. Messenger RNA (mRNA) : 3 outcomes 14 studies in 114 results : IBA
   
3. lapatinib (GW572016) : 2 outcomes 2 studies in 5 results : FDA 1
   
4. tumor-associated antigen GA733 : 1 outcome 5 studies in 53 results : IBA
   
5. Antigens : 1 outcome 4 studies in 28 results : IBA
   
6. Epidermal Growth Factor Receptor (EGF Receptor) : 1 outcome 1 study in 11 results : IBA
   
7. Fibrin : 1 outcome 1 study in 6 results : IBA
   
8. gemcitabine : 1 outcome 1 study in 3 results : FDA 7
   
9. 1-phenyl-3,3-dimethyltriazene (PDT) : 1 outcome 1 study in 2 results : IBA
   
10. Cytidine Deaminase : 1 outcome 1 study in 1 result : IBA
    

Diseases Related to Circulating Neoplastic Cells

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Carcinoma (Carcinomatosis)
4. Prostatic Neoplasms (Prostate Cancer)
5. Neoplasm Metastasis (Metastasis)

Key Therapies for Circulating Neoplastic Cells

1. Drug Therapy (Chemotherapy) : 3 outcomes 16 studies in 82 results
   
2. Castration : 1 outcome 4 studies in 44 results
   
3. Radiotherapy : 1 outcome 2 studies in 9 results
   
4. Heterologous Transplantation (Xenotransplantation) : 1 outcome 1 study in 20 results
   
5. Therapeutics : 1 outcome 1 study in 6 results